EUCTR2010-023226-20-BE进行中（未招募）1 期
Effect of the GLP-1 analogue liraglutide on intragastric pressure and satiation during nutrient drink infusion.
KULeuven0 个研究点目标入组 0 人开始时间: 2010年12月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy volunteers (18-45 years) who have no bowel symptoms and who are in good general health are eligible
- •for the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •They have relevant underlying disease (cardia, pulmonary, metabolic, kidney or liver disease, …)
- •They have a history of esophageal or gastric surgery, or recurrent or intermittent upper gastrointestinal
- •symptoms (upper abdominal pain, nausea, vomiting, bothersome fullness or early satiation, heartburn,
- •regurgitation,…)
- •They have a history of allergy to several types of drugs or food.
- •They have ever been treated for depression
- •There is a possibility of becoming pregnant during the study period.
研究者
相似试验
进行中（未招募）
1 期
EFFECTS OF THE GLP-1 RECEPTOR AGONIST LIRAGLUTIDE ON LOWER LIMB PERFUSION IN PEOPLE WITH TYPE 2 DIABETES AND PERIPHERAL ARTERY DISEASE: A RANDOMIZED CONTROLLED TRIAPeripheral Artery Disease and type 2 diabetes mellitusMedDRA version: 20.0Level: LLTClassification code 10053246Term: Type II diabetes peripheral angiopathySystem Organ Class: 100000004866EUCTR2020-002940-22-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli50
进行中（未招募）
不适用
Assessing the efficacy and safety of the GLP1-agonist liraglutide in patients who developed diabetes as a consequence of the use of anti-psychotic drugsEUCTR2013-005395-18-NLniversity Medical Center Utrecht
撤回
4 期
Effects of GLP1 agonist liraglutide in patients with antipsychotic-drugs-associated diabetes mellitus10018424Diabetes MellitusNL-OMON40321Interne geneeskunde50
进行中（未招募）
1 期
correlation between gastric motility and appetiteEUCTR2013-004946-41-BEKULeuven
进行中（未招募）
1 期
A pilot study in the use of the GLP-1 agonist liraglutide in the treatment of short bowelIntestinal failure with an underlying aetiology of short bowelMedDRA version: 20.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2016-004797-18-GBImperial College London5